Clinical Trials
3 trialsNCT07383506 2026-03-27
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Cogent Biosciences, Inc.
Phase 1 Not yet recruiting
NCT06754761 2025-01-01
Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
AstraZeneca
Phase 1 Not yet recruiting
NCT06614751 2024-09-27
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Danatlas Pharmaceuticals Co., Ltd
Phase 1 Not yet recruiting